Bath & Body Works, Inc. (NYSE:BBWI) Shares Sold by Guggenheim Capital LLC

Guggenheim Capital LLC cut its position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 37.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 28,482 shares of the company's stock after selling 16,726 shares during the quarter. Guggenheim Capital LLC's holdings in Bath & Body Works were worth $1,104,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently modified their holdings of BBWI. SRS Capital Advisors Inc. boosted its stake in Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock valued at $26,000 after buying an additional 329 shares in the last quarter. Golden State Wealth Management LLC acquired a new stake in Bath & Body Works in the 4th quarter valued at about $26,000. UMB Bank n.a. boosted its position in shares of Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after purchasing an additional 335 shares in the last quarter. Lindbrook Capital LLC grew its stake in shares of Bath & Body Works by 81.9% in the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock worth $37,000 after purchasing an additional 431 shares during the last quarter. Finally, Smartleaf Asset Management LLC raised its holdings in shares of Bath & Body Works by 135.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company's stock worth $39,000 after purchasing an additional 582 shares in the last quarter. Institutional investors own 95.14% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on BBWI. Telsey Advisory Group restated an "outperform" rating and set a $43.00 target price on shares of Bath & Body Works in a report on Thursday, February 27th. Barclays reduced their price objective on Bath & Body Works from $43.00 to $38.00 and set an "equal weight" rating for the company in a research note on Monday, March 3rd. Argus reaffirmed a "hold" rating on shares of Bath & Body Works in a research report on Friday, January 10th. Citigroup decreased their price target on Bath & Body Works from $48.00 to $36.00 and set a "buy" rating for the company in a research report on Monday, April 7th. Finally, Cowen restated a "buy" rating on shares of Bath & Body Works in a report on Thursday, February 27th. Four equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $42.69.

Bath & Body Works Trading Up 3.8 %

NYSE BBWI opened at $28.77 on Wednesday. The company has a market capitalization of $6.16 billion, a PE ratio of 7.02, a price-to-earnings-growth ratio of 0.92 and a beta of 1.69. Bath & Body Works, Inc. has a 1-year low of $24.96 and a 1-year high of $52.99. The firm's fifty day simple moving average is $31.83 and its 200-day simple moving average is $33.85.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, topping analysts' consensus estimates of $2.04 by $0.05. The company had revenue of $2.79 billion during the quarter, compared to the consensus estimate of $2.78 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. As a group, analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.78%. The ex-dividend date was Friday, February 21st. Bath & Body Works's dividend payout ratio is 21.98%.

Bath & Body Works announced that its board has initiated a stock repurchase plan on Thursday, February 27th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to reacquire up to 6.4% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's management believes its shares are undervalued.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.